These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 24113159

  • 1. Pituitary apoplexy associated with cabergoline therapy.
    Chng E, Dalan R.
    J Clin Neurosci; 2013 Dec; 20(12):1637-43. PubMed ID: 24113159
    [Abstract] [Full Text] [Related]

  • 2. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.
    Balarini Lima GA, Machado Ede O, Dos Santos Silva CM, Filho PN, Gadelha MR.
    Pituitary; 2008 Dec; 11(3):287-92. PubMed ID: 17570067
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
    Kawabata Y, Ueno Y, Horikawa F, Miyake H, Miki N, Ono M.
    Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy.
    Witek P, Zieliński G, Maksymowicz M, Zgliczyński W.
    Neuro Endocrinol Lett; 2012 Jan; 33(5):483-8. PubMed ID: 23090264
    [Abstract] [Full Text] [Related]

  • 7. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.
    Raverot G, Jacob M, Jouanneau E, Delemer B, Vighetto A, Pugeat M, Borson-Chazot F.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):588-92. PubMed ID: 18673461
    [Abstract] [Full Text] [Related]

  • 8. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
    Dhanwal DK, Sharma AK.
    Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
    [Abstract] [Full Text] [Related]

  • 9. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
    Castro-Castro J, Torre-Eiriz JA, Pinzón-Millán A, Pastor-Zapata A.
    Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
    [Abstract] [Full Text] [Related]

  • 10. Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
    Jouret F, Col V.
    Acta Clin Belg; 2009 Dec; 64(5):457. PubMed ID: 19999399
    [No Abstract] [Full Text] [Related]

  • 11. The cabergoline-resistant prolactinoma patient: new challenges.
    Molitch ME.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4643-5. PubMed ID: 19056842
    [No Abstract] [Full Text] [Related]

  • 12. Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment.
    Oguz A, Tuzun D, Sahin M, Gul K.
    Niger J Clin Pract; 2016 Dec; 19(5):685-7. PubMed ID: 27538562
    [Abstract] [Full Text] [Related]

  • 13. Cabergoline treatment in a case of macroprolactinoma after delivery.
    Falsetti L.
    Acta Eur Fertil; 1995 Dec; 26(3):105-7. PubMed ID: 9098469
    [Abstract] [Full Text] [Related]

  • 14. Resolution of third nerve palsy following treatment of prolactinoma with cabergoline.
    Harries AM, Gittoes NJ, Mitchell RD.
    Acta Neurochir (Wien); 2010 Oct; 152(10):1741-3. PubMed ID: 20623359
    [Abstract] [Full Text] [Related]

  • 15. Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.
    Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB.
    Pituitary; 2004 Oct; 7(2):83-7. PubMed ID: 15761656
    [Abstract] [Full Text] [Related]

  • 16. Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma.
    Kars M, Delgado V, Holman ER, Feelders RA, Smit JW, Romijn JA, Bax JJ, Pereira AM.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3348-56. PubMed ID: 18559921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pituitary Apoplexy in Long-Term Cabergoline User During Thrombocytopenia Due to Chemotherapy for Chronic Myelocytic Leukemia.
    Maki Y, Kurosaki Y, Uchino K, Ishibashi R, Chin M, Yamagata S.
    World Neurosurg; 2018 Dec; 120():290-295. PubMed ID: 30189305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prolactinoma and pregnancy].
    Trifonov I.
    Akush Ginekol (Sofiia); 2004 Dec; 43 Suppl 2():16-22. PubMed ID: 15518268
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.